A Stock You Ought To Watch Is Plus Therapeutics Inc. (NASDAQ: PSTV) – Marketing Sentinel
Home  »  Business   »  A Stock You Ought To Watch Is Plus Therapeutics In...

A Stock You Ought To Watch Is Plus Therapeutics Inc. (NASDAQ: PSTV)

During the recent session, Plus Therapeutics Inc. (NASDAQ:PSTV)’s traded shares were 0.72 million, with the beta value of the company hitting 0.37. At the last check today, the stock’s price was $2.41, reflecting an intraday gain of 3.96% or $0.09. The 52-week high for the PSTV share is $5.42, that puts it down -124.9 from that peak though still a striking 20.33% gain since the share price plummeted to a 52-week low of $1.92. The company’s market capitalization is $24.15M, and the average intraday trading volume over the past 10 days was 0.32 million shares, and the average trade volume was 978.75K shares over the past three months.

Plus Therapeutics Inc. (PSTV) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. PSTV has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.24.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Plus Therapeutics Inc. (NASDAQ:PSTV) trade information

Plus Therapeutics Inc. (PSTV) registered a 3.96% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.96% in intraday trading to $2.41 this Wednesday, 07/21/21, hitting a weekly high. The stock’s 5-day price performance is 3.11%, and it has moved by -9.73% in 30 days. Based on these gigs, the overall price performance for the year is -1.28%. The short interest in Plus Therapeutics Inc. (NASDAQ:PSTV) is 0.97 million shares and it means that shorts have 0.46 day(s) to cover.

The consensus price target of analysts on Wall Street is $6.63, which implies an increase of 63.65% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.25 and $7.00 respectively. As a result, PSTV is trading at a discount of -190.46% off the target high and -159.34% off the low.

Plus Therapeutics Inc. (PSTV) estimates and forecasts

Statistics show that Plus Therapeutics Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Plus Therapeutics Inc. (PSTV) shares have gone down -1.69% during the last six months, with a year-to-date growth rate more than the industry average at 47.31% against 16.70. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 46.70% this quarter and then jump 41.00% in the quarter after that.

While earnings are projected to return 32.90% in 2021.

PSTV Dividends

Plus Therapeutics Inc. is due to release its next quarterly earnings between August 09 and August 13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Plus Therapeutics Inc. (NASDAQ:PSTV)’s Major holders

Plus Therapeutics Inc. insiders own 1.33% of total outstanding shares while institutional holders control 2.25%, with the float percentage being 2.28%. Blackrock Inc. is the largest shareholder of the company, while 25 institutions own stock in it. As of Mar 30, 2021, the company held over 0.12 million shares (or 0.57% of all shares), a total value of $0.29 million in shares.

The next largest institutional holding, with 77086.0 shares, is of Vanguard Group, Inc. (The)’s that is approximately 0.37% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $0.19 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also, the Mutual Funds coming in first place with the largest holdings of Plus Therapeutics Inc. (PSTV) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Mar 30, 2021 indicates that Vanguard Extended Market Index Fund owns about 77086.0 shares. This amounts to just over 0.37 percent of the company’s overall shares, with a $0.19 million market value. The same data shows that the other fund manager holds slightly less at 6336.0, or about 0.03% of the stock, which is worth about $15206.0.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam